In breast cancer cells such as MCF-7, RLN2 has been primarily shown to induce NO production by upregulating inducible nitric oxide synthase (iNOS), possibly to promote increased blood flow and angiogenesis in these cells [9,10]. Here, RLN2 is linked to breast carcinoma.